Skip to main content
    N

    Neogen Corporation (NEOG)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $10.88
    -0.35 (-3.12%)

    Market Cap: $2.45B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Neogen Corporation (NEOG) Financials: Revenue, Profit and Cash Flow

    Updated Oct 6, 2026. Financial statements from company filings, amounts in US dollars.

    Neogen reported revenue of $870.40M for the fiscal year ended May 31, 2026, down 2.7% from the year before. That year, net income was -$7.90M with a net margin of -0.9%, operating cash flow was $83.20M and free cash flow was $31.90M. The quarter ended Aug 31, 2026 had revenue of $222.80M and net income of -$11.90M.

    Revenue and Margins

    The operating margin was -2.5% in the fiscal year ended May 2026, the lowest of the 9 years shown with an operating margin. Over the 9 years to May 2026, revenue grew from $358.28M, a compound annual rate of 10.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    May 2026$870.40M-2.7%46.9%-2.5%-0.9%
    May 2025$894.70M-3.2%47.1%-118.6%-122.1%
    May 2024$924.20M+12.4%50.2%6.3%-1.0%
    May 2023$822.45M+56.0%49.4%4.6%-2.8%
    May 2022$527.16M+12.5%46.1%11.1%9.2%
    May 2021$468.46M+12.0%45.9%15.8%13.0%
    May 2020$418.17M+1.0%46.9%16.1%14.2%
    May 2019$414.19M+4.1%46.3%16.4%14.5%
    May 2018$397.93M+11.1%46.8%17.6%15.9%
    May 2017$358.28MN/A47.1%18.1%12.3%
    Annual, fiscal years ended May 2017 to May 2026

    Income Statement

    In the fiscal year ended May 2026, the net loss narrowed from the year before. In the quarter ended Aug 2026, the company posted a net loss after a profit in the same quarter a year earlier.

    Annual

    Line itemMay 2026May 2025May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017
    Revenue$870.40M$894.70M$924.20M$822.45M$527.16M$468.46M$418.17M$414.19M$397.93M$358.28M
    Cost of revenue$461.90M$473.30M$460.30M$416.49M$284.15M$253.40M$221.89M$222.27M$211.66M$189.35M
    Gross profit$408.50M$421.40M$463.90M$405.95M$243.01M$215.06M$196.28M$191.92M$186.27M$168.92M
    Research and development$18.40M$21.10M$22.50M$26.04M$17.05M$16.25M$14.75M$12.80M$10.86M$10.38M
    Operating income-$21.60M-$1.06B$58.60M$37.52M$58.62M$74.17M$67.52M$68.09M$70.19M$64.94M
    Net income-$7.90M-$1.09B-$9.40M-$22.87M$48.31M$60.88M$59.48M$60.18M$63.22M$43.97M
    EBITDA$172.50M-$935.70M$177.30M$123.95M$83.07M$94.69M$84.71M$85.75M$88.33M$80.36M
    Fiscal years ended May 2017 to May 2026

    Quarterly

    Line itemAug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024Nov 2023
    Revenue$222.80M$225.32M$211.20M$224.69M$209.20M$225.48M$221.00M$231.26M$216.96M$236.79M$228.81M$229.63M
    Gross profit$105.50M$107.85M$99.00M$106.68M$95.00M$92.84M$110.30M$113.33M$104.93M$113.48M$116.88M$116.77M
    Operating income-$1.80M$3.17M-$3.30M-$5.38M-$16.10M-$611.17M$5.40M-$457.48M$2.26M$13.04M$12.02M$14.46M
    Net income-$11.90M-$11.31M-$17.00M-$15.92M$36.30M-$612.21M-$10.90M-$456.28M-$12.61M-$5.42M-$2.02M-$3.49M
    Last 12 quarters

    Balance Sheet

    As of May 2026, total debt of $793.70M exceeded cash and equivalents by $608.20M.

    Annual

    Line itemMay 2026May 2025May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017
    Total assets$3.35B$3.44B$4.55B$4.55B$992.93M$920.19M$797.18M$695.74M$618.01M$528.41M
    Current assets$604.60M$576.90M$589.23M$585.93M$626.80M$591.45M$537.41M$449.53M$375.79M$292.96M
    Cash and equivalents$185.50M$129.00M$170.61M$163.24M$44.47M$75.60M$66.27M$41.69M$83.07M$77.57M
    Total liabilities$1.25B$1.37B$1.40B$1.42B$105.56M$79.81M$72.00M$57.84M$57.83M$56.65M
    Short-term debt$0$19.30M$2.45M$6.55M$2.88M$1.28M$1.05MN/AN/AN/A
    Long-term debt$793.70M$874.80M$888.39M$885.44M$0N/AN/AN/A$0$0
    Shareholder equity$2.09B$2.07B$3.14B$3.13B$887.37M$840.38M$725.18M$637.90M$560.17M$471.61M
    Fiscal years ended May 2017 to May 2026

    Quarterly

    Line itemAug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024Nov 2023
    Total assets$3.30B$3.35B$3.36B$3.36B$3.38B$3.44B$4.04B$4.05B$4.50B$4.58B$4.58B$4.60B
    Total liabilities$1.22B$1.25B$1.26B$1.26B$1.26B$1.37B$1.38B$1.39B$1.37B$1.44B$1.44B$1.45B
    Cash and equivalents$172.00M$185.50M$159.90M$145.34M$138.88M$129.00M$127.70M$140.23M$120.48M$170.61M$161.44M$205.76M
    Shareholder equity$2.09B$2.09B$2.10B$2.10B$2.12B$2.07B$2.66B$2.67B$3.14B$3.14B$3.15B$3.15B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended May 2026, free cash flow was 38.3% of operating cash flow.

    Annual

    Line itemMay 2026May 2025May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017
    Operating cash flow$83.20M$58.20M$35.30M$41.03M$68.04M$81.09M$85.88M$63.84M$69.13M$60.27M
    Capital expenditures$51.30M$104.60M$111.40M$65.76M$24.43M$26.71M$24.05M$14.66M$20.95M$14.58M
    Free cash flow$31.90M-$46.40M-$76.10M-$24.73M$43.61M$54.38M$61.83M$49.18M$48.19M$45.70M
    Share repurchasesN/AN/AN/AN/AN/AN/AN/A$3.13M$0$0
    Investing cash flow$70.50M-$99.20M-$29.30M$201.04M-$97.23M-$105.56M-$88.78M-$119.15M-$83.08M-$62.14M
    Financing cash flow-$99.40M-$1.60M$1.90M-$118.08M$6.81M$33.54M$29.41M$13.90M$22.84M$25.07M
    Fiscal years ended May 2017 to May 2026

    Quarterly

    Line itemAug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024Nov 2023
    Operating cash flow$12.90M$30.20M$22.70M$19.44M$10.80M$16.40M$19.46M$40.25M-$17.91M$26.78M-$30.21M$15.71M
    Capital expenditures$8.20M$4.00M$11.63M$11.67M$24.00M$16.10M$32.91M$17.16M$38.43M$24.23M$32.12M$24.42M
    Free cash flow$4.70M$26.20M$11.07M$7.78M-$13.20M$300.00K-$13.45M$23.10M-$56.35M$2.55M-$62.33M-$8.70M
    Last 12 quarters

    Frequently Asked Questions About NEOG

    What is Neogen's annual revenue?

    Neogen reported revenue of $870.40M for the fiscal year ended May 31, 2026.

    How fast is Neogen's revenue growing?

    Revenue was down 2.7% for the fiscal year ended May 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 1.9%.

    Is Neogen profitable?

    No. Neogen reported net income of -$7.90M for the fiscal year ended May 31, 2026, with a net margin of -0.9%.

    How much free cash flow does NEOG generate?

    For the fiscal year ended May 31, 2026, operating cash flow of $83.20M minus capital expenditures of $51.30M produced free cash flow of $31.90M.

    How much debt does Neogen have?

    The balance sheet dated May 31, 2026 reported long-term debt of $793.70M, short-term debt of $0 and cash and equivalents of $185.50M.